Jacobs Levy Equity Management Inc. Takes $2.16 Million Position in Astrana Health, Inc. (NASDAQ:ASTH)

Jacobs Levy Equity Management Inc. acquired a new stake in Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 37,190 shares of the company’s stock, valued at approximately $2,155,000.

A number of other institutional investors have also added to or reduced their stakes in ASTH. FMR LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $48,413,000. SteelPeak Wealth LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $39,398,000. Loomis Sayles & Co. L P acquired a new position in Astrana Health during the 3rd quarter worth approximately $30,251,000. NorthCrest Asset Manangement LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $26,704,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in Astrana Health during the 3rd quarter worth approximately $25,945,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ASTH. Robert W. Baird upped their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. TD Cowen assumed coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective for the company. KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Astrana Health currently has an average rating of “Buy” and an average price target of $65.17.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $41.41 on Friday. The company has a market cap of $2.33 billion, a PE ratio of 31.85, a price-to-earnings-growth ratio of 2.03 and a beta of 1.13. Astrana Health, Inc. has a 52 week low of $32.32 and a 52 week high of $63.20. The business has a 50 day moving average price of $51.49 and a 200-day moving average price of $48.10. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33. The company had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the prior year, the company posted $0.47 earnings per share. Equities analysts anticipate that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.